Let's GO, @ummuhub and @DEPHNetwork.
For ALL women out there, this is for you. @ummuhub is designed for your own biology. Because you are different in each and every aspect. You are UNIQUE. You have INDIVIDUALITY. You are YOU.
Can DNA methylation in saliva help distinguish fibromyalgia? ๐ฌ
Weโve developed the Ajaz/Collins Fibromyalgia DNA Saliva Test, Version 1.0, a research score based on methylation at 230 CpG sites. Scoring a sample requires only saliva methylation measurements.
We identified candidate sites in an initial discovery study, then developed the score in a separate cohort of 1,928 people, including 31 with recorded fibromyalgia. In repeated nested cross-validation, the score achieved a mean ROC AUC of 0.73. Among the 663 participants who reported monthly pain, the mean AUC was 0.72.
That subgroup is especially interesting to us. It asks whether the methylation signal can distinguish people with recorded fibromyalgia even when everyone in the comparison reports pain.
If you work with a fibromyalgia or chronic pain cohort and would like to collaborate on validation, Iโd welcome a conversation.
@DEPHNetwork@saimaajazshah
DOI: https://t.co/5Ns7Cz9fDY
#fibromyalgia #chronicpain #fatigue #WomensHealth
๐This is where CT usually gets it wrong.
$DEPH is sitting around a ~$3.0M market cap on Base, with ~$42K 24H volume and just ~$24K liquidity. Price is around $0.00826 after a -2.66% 24H move.
To me, that doesnโt scream dead.
It screams early, illiquid, under-the-radar and massively asymmetrical. ๐๐ฅ
369M fixed supply.
ENGNE โข UMMU โข MUHDO.
Token LIVE on Base.
DEPH chain still in development.
If this ecosystem starts translating vision into adoption, a ~$3M valuation could look insanely small in hindsight.
Yes, itโs risky.
Thatโs exactly why itโs interesting.
This feels like the kind of chart people ignore firstโฆ and chase later.
CA: 0x83f641e13ccfde2c9d07b0897027ef1523884d21
@DEPHNetwork
#DEPH #DeSci #Base
๐๐๐ฆ๐๐ง๐ญ๐ข๐ ๐ก๐๐ฌ ๐ซ๐๐ซ๐๐ฅ๐ฒ ๐๐๐๐ง ๐จ๐ฎ๐ญ ๐จ๐ ๐ญ๐ก๐ ๐๐ ๐ง๐๐ฐ๐ฌ ๐ญ๐ก๐ข๐ฌ ๐๐ฎ๐ญ๐ฎ๐ฆ๐ง. ๐ง
The Prime Minister announced a ยฃ48m public-private partnership to speed up dementia research and trial access.
Alzheimer's Research UK has called for a dedicated Dementia Drugs Fund. And this week, the 20th UK Dementia Congress takes place in Doncaster.
The attention is overdue. But the research keeps pointing to one word.
Early.โฑ๏ธ
New treatments are expected to work best in the early stages of the disease. WHO guidance says up to 45% of dementia risk could be prevented or delayed. If the window opens years before symptoms, waiting for symptoms is too late.
Thatโs where epigenetics comes in. DNA methylation changes ๐งฌ over time and is associated with sleep, activity, diet, smoking and stress.
Your genes are fixed. Your methylation is not.
At Muhdo Health, weโre proud to be part of two European ๐ช๐บ Alzheimerโs programmes.
๐๐๐๐๐๐๐๐๐: a โฌ21m project led by Kingโs College London, uniting 30 partners across 15 countries, including Novo Nordisk, GE HealthCare, Siemens Healthineers and Alzheimer Europe.
Together, weโre building a screening platform to identify people at risk of dementia before symptoms appear.
๐๐๐๐๐๐-๐๐: launched in January 2026, turning science into real-world care, including a pilot testing drug therapies alongside lifestyle interventions.
Both point the same way. Earlier insight. More testing at home. Lifestyle as part of the plan.
Our epigenetic test measures 9 biological and organ ages from a saliva sample, including Memory Age. ๐ง
It is not a dementia diagnosis. Itโs an early, personal signal of how one part of your biology is ageing. Results can change, so you can retest to see whether lifestyle changes are showing up.
You can start today. Keep active. Protect your sleep. Manage your blood pressure. Look after your hearing. Stay connected. Donโt smoke and keep alcohol low.
The biggest gains may come years before diagnosis.
If you would like further information regarding any of the areas above, please email [email protected] ๐งฌ
Better health, backed by science ๐งฌ
#Dementia #Alzheimers #BrainHealth #Epigenetics #Longevity #PreventativeHealth #Muhdo
๐จ Everyone wants to find a hidden gem. Few actually look at the tokenomics. ๐๐ฅ
$DEPH is trading on Base at roughly a $3M valuation.
Small cap. Thin liquidity. Still early.
But hereโs what caught my attention. ๐
@DEPHNetworkโs token whitepaper outlines:
๐ฅ 369M fixed supply ๐ฅ 20โ30% fees on network-provided services, settled in $DEPH ๐ฅ 50% of those fees burned
These mechanics are proposed, not yet live. The dedicated DEPH chain is still being developed.
Now imagine ENGNE, UMMU and MUHDO bringing real adoption into that ecosystem.
Thatโs the thesis. Execution is the key.
Iโm keeping a VERY close eye on this one. ๐
CA: 0x83f641e13ccfde2c9d07b0897027ef1523884d21
DYOR: https://t.co/nSRgj3xotUโ
#DEPH #DeSci #Base
Real #DeSci in actionโnot vaporware! ๐งฌ๐
DEPH Labs just released LifeGiver, an open, saliva-based DNA methylation clock validated across 4,900 people and published free on Zenodo. Real science + real utility powering $DEPH on Base! ๐ฆพโก
๐จ CT, $DEPH is still flying under the radar. ๐๐ฅ
Fresh Base chart:
๐ ~$3M market cap
๐ 24H: +3.65%
๐ 6H: -2.96%
๐ฐ 24H volume: ~$26K
๐ง Liquidity: ~$24K
No confirmed breakout yet. But look beyond the candles.
369M fixed supply. ENGNE, UMMU & MUHDO behind a much bigger ecosystem vision.
@DEPHNetwork has its token trading on Base while its own chain is still being built.
Tiny liquidity means serious risk, but the upside thesis if adoption follows is what keeps me watching.
Early-stage DeSci. Big ambitions. Plenty to prove.
Are degens sleeping on this one? ๐
CA: 0x83f641e13ccfde2c9d07b0897027ef1523884d21
#DEPH #DeSci #Base
Introducing LifeGiver: an open, saliva-based DNA methylation clock from DEPH Labs.
In validation, carriers of the FOXO3 longevity allele (rs2802292 G) showed lower epigenetic age acceleration.
The model is free on Zenodo. Test it. Break it. Build on it.
$DEPH is flying under CTโs radar. ๐งฌ๐ฅ
Most projects launch a token, then search for utility.
@DEPHNetwork spent years building first.
๐งฌ DNA, epigenetics & Health AI
๐ ENGNE, UMMU & MUHDO ecosystem
โก Web3 infrastructure & token utility
๐ 369M fixed supply
Now $DEPH is LIVE on Base.
Years of development. Real products. A token economy designed around network usage.
If adoption scales, things could get very interesting. ๐๐
Base CA:
0x83f641e13ccfde2c9d07b0897027ef1523884d21
#DEPH #DeSci #Base
@DEPHNetwork $DEPH is the FUTURE of Health AI.
Your OWN health data, you have the power to it. Not owned by third party. You have the control over it and can capitalize on it.
๐จ CT loves being EARLYโฆ until itโs actually early. ๐๐ฅ
$DEPH is sitting at just ~$3.1M market cap!
๐ 369M fixed supply
๐ +3.26% (24H)
๐งฌ ENGNE, UMMU & MUHDO ecosystem
Not another copy-paste meme. Thereโs a much bigger vision behind @DEPHNetwork.
Token LIVE on Base. Dedicated chain still being built.
Tiny liquidity, big risks, HUGE ambitions.
Iโm watching this one closely. ๐๐
CA: 0x83f641e13ccfde2c9d07b0897027ef1523884d21
#DEPH #DeSci #Base
๐จ CT loves being EARLYโฆ until itโs actually early. ๐๐ฅ
$DEPH is sitting at just ~$3.1M market cap!
๐ 369M fixed supply
๐ +3.26% (24H)
๐งฌ ENGNE, UMMU & MUHDO ecosystem
Not another copy-paste meme. Thereโs a much bigger vision behind @DEPHNetwork.
Token LIVE on Base. Dedicated chain still being built.
Tiny liquidity, big risks, HUGE ambitions.
Iโm watching this one closely. ๐๐
CA: 0x83f641e13ccfde2c9d07b0897027ef1523884d21
#DEPH #DeSci #Base
23andMeโs bankruptcy exposed a massive flaw in personal health tech: when a company gets sold, your privacy policy goes on the auction block too.
โAn AI wellness coach that knows your biology and habits for 20 years shouldn't hold permanent custody of your history.
โAs featured in The Biotech Codex, Secret Networkโs confidential computing infrastructure (and Secret Zone) lets @DEPHNetwork's planned platform compute on encrypted health records, giving AI useful context while leaving revocation and access control strictly in the userโs hands.
โRemembering you shouldn't mean owning you.
โRead the breakdown ๐
https://t.co/mTRUaqVlnk
Men and women age differently, so why would one measurement work equally well for both?
That's why our research starts from sex-specific epigenetic clocks, with ENGNE for Her for women and ENGNE for men. (3/4)
We have more health data about us than ever. Your doctor has some, your wearable has some, a testing company has another piece.
Bringing it together should keep the individual at the center, with control over who sees what. (2/4)
Your DNA is about as personal as data gets, and unlike a password you can't change it after a breach.
That's why I care so much about who holds our health data. (1/4)